在癌症治疗期间,使用"在家治疗症状"数字平台的步骤数和症状严重程度
Bridget Nicholson1, Ann Marie Moraitis2, Keiko Cawley3
1University of Utah, 10 S 200 East, Salt Lake City, UT, 84112, USA. bridget.nicholson@nurs.utah.edu.
概括
癌症患者的症状负担,通过电子患者报告结果 (ePRO) 来衡量,与减少每日步数有关. 疲劳显著影响活动水平,而不是恶心,吐或疼痛.
科学领域:
- 在瘤学瘤学.
- 数字健康数字健康
- 患者报告的结果
背景情况:
- 系统性癌症治疗往往会导致患者显著的症状负担.
- 电子患者报告结果 (ePRO) 改善了症状监测,但组合的主观和客观措施尚未得到充分研究.
- 这项研究调查了癌症患者患者报告的症状和身体活动 (步数) 之间的联系.
研究的目的:
- 探索瘤症状与每日步数之间的关系.
- 评估将ePRO与客观活动监测相结合的实用性.
- 识别正在接受治疗的癌症患者影响身体活动的关键症状.
主要方法:
- 一个使用Symptom Care at Home (SCH) 平台的二次分析.
- 参与者通过ePRO.com报告了11种常见的癌症治疗症状.
- 使用Garmin活动监控器收集了目标步数数据.
主要成果:
- 共有339名参与者提供了活动监测数据,54%的人报告了症状和步数.
- 总症状严重程度每增加1个点都与大约46个每日步骤的减少有关.
- 疲劳与活动减少的关联最强,其次是恶心/吐和疼痛.
结论:
- 在接受全身癌症治疗的患者中,ePRO报告的症状和步数之间存在显著的关系.
- 疲劳成为对身体活动最有影响的症状,超过了恶心,吐和疼痛.
- 结合ePRO和步数计算,有可能改善瘤治疗中的症状监测和临床反应.
相关概念视频
Documentation in Long-Term and Home Healthcare Setting
987
Documentation in long-term care facilities and home healthcare settings is crucial for ensuring continuous, coordinated, and comprehensive care for patients. Each setting has its specific documentation processes and tools:
Long-Term Care Facilities
Long-Term Care Facilities
987
Cancer Therapies
7.9K
Cancer therapies are various modes of treatment, such as surgery, radiation therapy, and chemotherapy that are administered to cancer patients.
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
7.9K
Cancer Survival Analysis
455
Cancer survival analysis focuses on quantifying and interpreting the time from a key starting point, such as diagnosis or the initiation of treatment, to a specific endpoint, such as remission or death. This analysis provides critical insights into treatment effectiveness and factors that influence patient outcomes, helping to shape clinical decisions and guide prognostic evaluations. A cornerstone of oncology research, survival analysis tackles the challenges of skewed, non-normally...
455


